跳至主要内容
临床试验/CTRI/2025/03/082804
CTRI/2025/03/082804尚未招募3 期

A comparativw clinical study to evaluate the therapeutic effect of pippalyadi churna and sitophaladi churna in the management of kaphaja kasa VIS-A-VIS Allergic bronchitis

Muniyal institute of ayurveda medical sciences1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年4月15日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
To reduce the respiratory complaints

研究概览

简要总结

Kasa is one of the most common diseases affecting the pranavaha srotas. If not treated, it may lead to dreadful diseases like Shwasa and Kshaya. According to the Acharyas, kasa is of 5 types, Kaphaja kasa being one among them. Kasa (cough) is the disease or symptom of respiratory tract occurring due to obstruction of Vata Dosha and its reverse movement and also a symptom of many other diseases. Kaphaja Kasa is dominated by Vata and Kapha and its nidana, samprapti, lakshanas, upadravas, and chikitsa are explainedin the classicS

The lakshanas of kaphaja kasa are similar to Allergic bronchitis or Chronic bronchitis & it has become more prevalent these days because of cigarette smoking. environmental pollution, occupational hazrds. In kaphaja kasa lakshanas are bahula, madhura, snigdha, swetha, nishtiva, ghana kapha, aruchi, gaurava, shirashoola, swarabheda, peenasa, kantha kandu, utklesha etc. Early intervention is necessary in case of kasa as it is a potential nidanarthkara vyadhi (disease itself become causative factor for other disease) to produce kshaya i.e depletion of bodily tissues/ dhatus. According to Ayurveda Chikitsa Siddhant, the prime treatment for Kaphaja Kasa is Nidana Parivarjana and the formulations which are Vata-kapha hara, Vatanulomana Agnideepana, Aama pachana and Srotoshodhaka. Keeping these points in mind an attempt is made to achieve these goals through Ayurvedic medicine. Pippalyadi churna is taken for the clinical study by considering the qualities of ingredients and cost effectiveness.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients with classical symptoms of kaphaja kasa bahula, madhura, shwet snigdha, nishtiva, ghana kapha, gourava, aruchi, shirashoola, swarabheda, peenasa, utklesha, mandagni Patients aged between 20-60 years of either gender.
  • Allergic bronchitis ranges from mild to moderate.

排除标准

  • Diagnosed patients with DM/HTN Diagnosed patients with Emphysema,CHD, Pnuemothorax, Septicemia, Haemoptysis, pneumonia, TB, Interstitial lung diseases Pregnant women and lactating mother Diagnosed patients with covid-19.

结局指标

主要结局

To reduce the respiratory complaints

时间窗: 15 days

次要结局

未报告次要终点

研究者

发起方
Muniyal institute of ayurveda medical sciences
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验